BAP1肿瘤易感综合征患者脑膜瘤高发且亚型独特
该回顾性队列研究纳入两个独立中心共237例携带胚系BAP1致病或可能致病变异者,发现6.8%(16/237)有脑膜瘤病史,平均诊断年龄44.5岁(17–71),可评估病理者中61.5%(8/13)为2/3级,83.3%(5/6)显示BAP1双等位基因失活。作者认为高级别脑膜瘤属于BAP1-TPDS临床谱系,建议青春期前后开始颅脊轴影像监测。
要点
- BAP1-TPDS患者脑膜瘤患病率6.8%,平均诊断年龄44.5岁。
- 可评估肿瘤中61.5%为2/3级,83.3%存在BAP1双等位基因失活。
- 建议BAP1-TPDS人群青春期前后开始颅脊轴影像监测。
核心结论
- 高级别脑和脊髓脑膜瘤是BAP1-TPDS临床谱系的一部分。
- BAP1-TPDS人群应考虑从青春期前后开始颅脊轴影像监测,以实现早期发现和管理。
研究设计与样本
- 回顾性病历审查两个独立队列中携带胚系BAP1致病或可能致病变异(P/LP)患者的脑膜瘤。
- 队列来自俄亥俄州立大学Wexner医学中心和纪念斯隆凯特琳癌症中心,时间范围为2010年10月1日至2025年4月21日。
- 另对携带胚系BAP1(P/LP)变异个体的脑膜瘤病例研究进行了文献综述。
主要发现
- 237例BAP1-TPDS受试者中,6.8%(16/237)有脑膜瘤病史。
- 平均诊断年龄为44.5岁(范围17–71岁)。
- 有病理可用的患者中,61.5%(8/13)的肿瘤为2/3级。
- 有肿瘤组织可用的患者中,83.3%(5/6)显示BAP1双等位基因失活证据。
- 18.8%(3/16)的患者报告有脑膜瘤家族史。
关键数值与推荐
- BAP1-TPDS患者脑膜瘤病史比例为6.8%(16/237)。
- 可评估病理的脑膜瘤中2/3级占61.5%(8/13)。
- 可评估肿瘤组织中BAP1双等位基因失活占83.3%(5/6)。
- 脑膜瘤家族史报告率为18.8%(3/16)。
临床怎么用
- 对BAP1-TPDS患者应关注脑膜瘤发生风险,包括高级别脑和脊髓脑膜瘤。
- 可考虑在BAP1-TPDS人群中从青春期前后开始颅脊轴影像监测。
- 对BAP1-TPDS相关脑膜瘤应进行病理分级和BAP1双等位基因失活评估。
局限性
- 本研究为回顾性病历审查,部分患者病理或肿瘤组织不可用。
- 文献综述中已发表病例与早期发病、高级别肿瘤和临床表型一致,但样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: BAP1-tumor predisposition syndrome (BAP1-TPDS) is associated with four main cancers: uveal melanoma, cutaneous melanoma, malignant mesothelioma, and renal cell carcinoma. However, additional cancers are found more rarely in BAP1-TPDS patients. The aim of this study was to investigate the association, clinical, and pathologic characteristics of meningioma in BAP1-TPDS. METHODS: We conducted a retrospective chart review of meningiomas in two independent cohorts of patients with germline BAP1 pathogenic or likely pathogenic (P/LP) variants at The Ohio State University Wexner Medical Center and at the Memorial Sloan Kettering Cancer Center from October 1st, 2010 date to April 21st, 2025. Additionally, we conducted a literature review of meningioma case studies for individuals with germline BAP1 (P/LP) variants. RESULTS: In a cohort of 237 subjects with BAP1-TPDS, we identified 6.8% (16/237) with a history of meningiomas. The average age of diagnosis was 44.5 years (17–71). For patients with available pathology, 61.5% (8/13) of the tumors were grade 2/3. Patients with available tumor tissue 83.3% (5/6) showed evidence of BAP1 biallelic inactivation. Family history of meningioma was reported in 18.8% (3/16) of patients. Four cases of meningioma were identified during meningioma surveillance imaging, and five cases had recurrences after treatment. Published cases were consistent with the early age of onset, high-grade tumors, and clinical phenotype of tumors. CONCLUSION: This study provides additional evidence that high-grade brain and spinal meningiomas are part of the clinical spectrum of BAP1-TPDS. Craniospinal imaging surveillance in the BAP1-TPDS population should be considered starting around puberty, enabling early detection and management for individuals with BAP1-TPDS.
引用
- Ramsey KA, Byrne L, Taylor OB, et al. High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome. J Neurooncol. 2026. PMID: 41670784. doi:10.1007/s11060-026-05445-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。